US Stock MarketDetailed Quotes

ICLR Icon PLC

Watchlist

189.640
-10.380-5.19%

Close Nov 15 16:00 ET

190.600
+0.960+0.51%

Post 20:01 ET

15.66BMarket Cap21.09P/E (TTM)

Icon PLC Stock Forum

Moomoo AI

Oct 28, 2023 07:46

While ICON's earnings forecast dipped slightly, the consensus price target remains unchanged. Despite the slower expected revenue growth, ICON is still predicted to outperform the wider industry growth.

ICON Public Limited Company (NASDAQ:ICLR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Analysts Notebook

May 24, 2022 06:18

Columns Top upgrades and downgrades on 5/24

Upgrades
• $Marqeta (MQ.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $15
• $Northwest Natural (NWN.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $53 (from $51)
• $Otis Worldwide (OTIS.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $82 (from $80)
• $Snowflake (SNOW.US)$ : Rosenblatt Upgrades to Buy from Neutral - PT $255 (from $325)
Downgrades
• $Eaton (ETN.US)$ : Barclays Downgrades to Underweight from Eq...

Analysts Notebook

Apr 12, 2022 06:39

Columns Top upgrades and downgrades on 4/12

Upgrades
• $Aptiv PLC (APTV.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $112 (from $108)
• $ASM INTERNATIONAL NV SPON ADR EACH REP 1 ORD SHS (ASMIY.US)$ : Barclays Upgrades to Overweight from EqualWeight - PT $425 (from $300)
• $Brighthouse Financial (BHF.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $54 (from $53)
• $Cardinal Health (CAH.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $74 (from $54)
• $CrowdStrike (CRWD.US)$ : Goldman...

win 11118

Nov 14, 2021 18:00

$Icon PLC (ICLR.US)$ nice

Jacinthen

Nov 5, 2021 04:12

Biotech and Research Stocks

$Bristol-Myers Squibb (BMY.US)$ $Takeda Pharmaceutical (TAK.US)$ $PPD Inc (PPD.US)$ $Icon PLC (ICLR.US)$ Anyone have any input on some of these Biotech and Research stocks below. Some of them are trading at pretty high prices. Yet a few of them are priced low and was wondering if now would be a good time to get in and hold for a long time. Thank you for any input or discussion.
Bristol-Myers Squibb Company (BMY)
Takeda Pharmaceutical Company (TAK)
PPD Inc (PPD)
ICON Public Limited Company (ICLR)
Charles Rivers Laboratories International (CRL)
Laboratory Corporation of America (LH)
IDEXX Laboratories Inc (IDXX)
Bio-Rad Laboratories Inc (BIO)